Mirum Pharmaceuticals: Q4 Earnings Insights

Mirum Pharmaceuticals MIRM reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Mirum Pharmaceuticals missed estimated earnings by -175.0%, reporting an EPS of $-0.66 versus an estimate of $-0.24.

Revenue was up $41.65 million from the same period last year.

Last quarter the company beat on EPS by $0.08 which was followed by a 6.0% increase in the share price the next day.

Here's a look at Mirum Pharmaceuticals's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.65	-0.81	-0.94	-1.02
EPS Actual	-0.57	-1.94	-0.80	-0.99
Revenue Estimate	37.12M	30.00M	28.69M	24.57M
Revenue Actual	47.73M	37.50M	31.60M	27.91M

To track all earnings releases for Mirum Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar